Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
Neuromuscular Disorders ; Volume: 17 ; Page: 955-959
Article in a journal
Médecine/Sciences ; Volume: 23 ; Page: 1080-1082
Article in a journal
Nature Genetics ; Volume: 39 ; Page: 1134-9
Article in a journal
Traffic ; Volume: 8 ; Page: 1052-67
Article in a journal
Médecine/Sciences ; Volume: 23 ; Page: 1080-1082
Article in a journal
Nature Genetics ; Volume: 38 ; Page: 1369-71
Article in a journal
Human Molecular Genetics ; Volume: 15 ; Page: 3098-106
Article in a journal
Molecular Biology of the Cell ; Volume: 17 ; Page: 3062-74
Article in a journal
Archives of Neurology -Chigago- ; Volume: 62 ; Page: 962-6
Article in a journal
American Journal of Medical Genetics Part A ; Volume: 134 ; Page: 338-40
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
On
12/102025
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: